{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:22:02Z","timestamp":1793834522632,"version":"4.6.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.neurol.2009.06.003","type":"journal-article","created":{"date-parts":[[2009,8,16]],"date-time":"2009-08-16T04:12:53Z","timestamp":1250395973000},"page":"845-856","source":"Crossref","is-referenced-by-count":134,"title":["\u00c9valuation des troubles comportementaux hyper- et hypodopaminergiques dans la maladie de Parkinson"],"prefix":"10.1016","volume":"165","author":[{"given":"C.","family":"Ardouin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Ch\u00e9reau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Lhomm\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Pollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Krack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2009.06.003_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances in patients with Parkinson's disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib2","first-page":"365","article-title":"Parkinson's disease is a neuropsychiatric disorder","volume":"91","author":"Agid","year":"2003","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib3","first-page":"211","article-title":"Biochemical substrates of mental disturbances in Parkinson's disease","volume":"40","author":"Agid","year":"1984","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib4","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/978-3-211-45295-0_61","article-title":"Neurosurgery in Parkinson's disease: the doctor is happy the patient less so?","volume":"70","author":"Agid","year":"2006","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neurol.2009.06.003_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.37.2.121","article-title":"The subcortical dementia of progressive supranuclear palsy","volume":"37","author":"Albert","year":"1974","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"S16","key":"10.1016\/j.neurol.2009.06.003_bib6","first-page":"S158","article-title":"A guided interview to assess behaviour in Parkinson's disease","volume":"22","author":"Ardouin","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib7","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/mds.21098","article-title":"Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation","volume":"21","author":"Ardouin","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib8","first-page":"791","article-title":"L-Dopa therapy in Parkinson's disease: a critical review of 9years experience","volume":"101","author":"Barbeau","year":"1969","journal-title":"Can Med Ass J"},{"key":"10.1016\/j.neurol.2009.06.003_bib9","first-page":"824","article-title":"Dopamine and disease","volume":"103","author":"Barbeau","year":"1970","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.neurol.2009.06.003_bib10","unstructured":"Barbeau A, Sourkes TL, Murphy GF. Les cat\u00e9cholamines dans la maladie de Parkinson. In: J, D.A., Ed. Monoamines et syst\u00e8me nerveux central (Symposium de Bel Air, Gen\u00e8ve, Sept 1961). Georg & Cie, Geneva, p.\u00a0247\u2013262."},{"key":"10.1016\/j.neurol.2009.06.003_bib11","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJM199905133401905","article-title":"Transient acute depression induced by high-frequency deep-brain stimulation","volume":"340","author":"Bejjani","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/j.neurol.2009.06.003_bib12","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1212\/01.WNL.0000031428.31861.23","article-title":"Aggressive behavior induced by intraoperative stimulation in the triangle of Sano","volume":"59","author":"Bejjani","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/brain\/117.4.859","article-title":"The behavioural and motor consequences of focal lesions of the basal ganglia in man","volume":"117","author":"Bhatia","year":"1994","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.06.003_bib14","first-page":"787","article-title":"Der L-3,4-Dioxyphenylalanin (Dopa) Effekt bei der Parkinson-Akinese","volume":"73","author":"Birkmayer","year":"1961","journal-title":"Klin Wschr"},{"key":"10.1016\/j.neurol.2009.06.003_bib15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.neurol.2008.01.002","article-title":"Dopamine dysregulation syndrome in Parkinson's disease","volume":"164","author":"Borg","year":"2008","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2009.06.003_bib16","first-page":"222","article-title":"Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy","volume":"10","author":"Botez","year":"1975","journal-title":"Int J Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2009.06.003_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/1801200a0","article-title":"3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonsists","volume":"180","author":"Carlsson","year":"1957","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2009.06.003_bib19","first-page":"577","article-title":"Psychiatric disturbances in Parkinson's disease","volume":"33","author":"Celesia","year":"1972","journal-title":"Dis Nerv Syst"},{"key":"10.1016\/j.neurol.2009.06.003_bib20","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1093\/cercor\/11.12.1136","article-title":"Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands","volume":"11","author":"Cools","year":"2001","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neurol.2009.06.003_bib21","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM196702162760703","article-title":"Aromatic amino acids and modification of parkinsonism","volume":"276","author":"Cotzias","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.06.003_bib22","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJM196902132800701","article-title":"Modification of parkinsonism: chronic treatment with L-Dopa","volume":"280","author":"Cotzias","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.06.003_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1176\/ajp.149.4.443","article-title":"Depression and Parkinson's disease: a review","volume":"149","author":"Cummings","year":"1992","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib24","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib25","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.21949","article-title":"Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom","volume":"23","author":"Czernecki","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib26","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00415-006-0177-0","article-title":"Does subthalamic nucleus stimulation induce apathy in Parkinson's disease?","volume":"253","author":"Drapier","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ana.410220108","article-title":"Cholinergic-dependent cognitive deficits in Parkinson's disease","volume":"22","author":"Dubois","year":"1987","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib28","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0035-3787(07)90458-0","article-title":"Apathie et pathologies neurod\u00e9g\u00e9neratives\u00a0: physiopathologie, \u00e9valuation diagnostique et traitement","volume":"163","author":"Dujardin","year":"2007","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2009.06.003_bib29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin Wochenschrift"},{"key":"10.1016\/j.neurol.2009.06.003_bib30","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.06.003_bib31","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/mds.20045","article-title":"Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome","volume":"19","author":"Evans","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/01.wco.0000137528.23126.41","article-title":"Dopamine dysregulation syndrome in Parkinson's disease","volume":"17","author":"Evans","year":"2004","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib33","unstructured":"Recommendations of the jury on diagnosis and treatment of Parkinson disease. Long text. Rev Neurol (Paris) 2000;156(Suppl. 2 Pt 2):281\u201394."},{"issue":"Pt 4","key":"10.1016\/j.neurol.2009.06.003_bib34","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.06.003_bib35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/jnnp.2002.009803","article-title":"Long-term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood and behaviour in Parkinson's disease","volume":"75","author":"Funkiewiez","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib36","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/mds.10441","article-title":"Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease","volume":"18","author":"Funkiewiez","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib37","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0140-6736(86)90617-3","article-title":"Levodopa treatment may benefit or impair \u201cfrontal\u201d function in Parkinson's disease","volume":"II","author":"Gotham","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2009.06.003_bib38","first-page":"571","article-title":"Perte de l\u2019\u00e9lan vital, de l\u2019int\u00e9r\u00eat et de l\u2019affectivit\u00e9, (syndrome athymhormique) au cours de l\u00e9sions lacunaires des corps stri\u00e9s","volume":"144","author":"Habib","year":"1988","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jnnp.72.6.701","article-title":"Behavioural disorders. Parkinson's disease and subthalamic stimulation","volume":"72","author":"Houeto","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib40","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.30.12.1326","article-title":"Is the mesocortical dopaminergic system involved in Parkinson disease?","volume":"30","author":"Javoy-Agid","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0165-0327(83)90006-X","article-title":"Antiparkinsonian and antidepressant effects of high doses of bromocriptine. An independent comparison","volume":"5","author":"Jouvent","year":"1983","journal-title":"J Affect Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib42","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.1174","article-title":"Mirthful laughter induced by subthalamic nucleus stimulation","volume":"16","author":"Krack","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1531-8257(200007)15:4<613::AID-MDS1005>3.0.CO;2-F","article-title":"Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a 2-year follow-up study of previously untreated patients","volume":"15","author":"Kulisevsky","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib44","first-page":"397","article-title":"La perte d\u2019auto-activation psychique","volume":"146","author":"Laplane","year":"1990","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib45","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jnnp.47.4.377","article-title":"Pure psychic akinesia with bilateral lesions of basal ganglia","volume":"47","author":"Laplane","year":"1984","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/brain\/106.2.257","article-title":"Cognitive deficits in the early stages of Parkinson's disease","volume":"106","author":"Lees","year":"1983","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.06.003_bib47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/jnp.10.3.314","article-title":"Apathy is not dpression","volume":"10","author":"Levy","year":"1998","journal-title":"J Neuropsy Clin Neurosci"},{"key":"10.1016\/j.neurol.2009.06.003_bib48","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.neurol.2009.06.003_bib49","series-title":"Die Lehre vom Tonus und der Bewegung","author":"Lewy","year":"1923"},{"issue":"Suppl. 16","key":"10.1016\/j.neurol.2009.06.003_bib50","first-page":"S167","article-title":"Improvement in hyperdopaminergic behaviours by subthalamic nucleus (STN) stimulation","volume":"22","author":"Lhommee","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib51","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM199810153391603","article-title":"Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease","volume":"339","author":"Limousin","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neurol.2009.06.003_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s004150050131","article-title":"The correlation of depression with functional activity in Parkinson's disease","volume":"244","author":"Liu","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib53","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/WNL.45.9.1757","article-title":"Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study","volume":"45","author":"Maricle","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1176\/ajp.147.1.22","article-title":"Differential diagnosis and classification of apathy","volume":"147","author":"Marin","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1176\/jnp.7.1.23","article-title":"Apathy: a treatable syndrome","volume":"7","author":"Marin","year":"1995","journal-title":"J Neuropsy Clin Neurosci"},{"key":"10.1016\/j.neurol.2009.06.003_bib56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.870050210","article-title":"Mood changes and \u201con-off\u201d phenomena in Parkinson's disease","volume":"5","author":"Menza","year":"1990","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib57","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I","article-title":"Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment","volume":"15","author":"Molina","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib58","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/jnnp.57.9.1034","article-title":"A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a 5-year follow up","volume":"57","author":"Montastruc","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib59","first-page":"369","article-title":"\u00c9tudes sur les complications et les s\u00e9quelles mentales de l\u2019enc\u00e9phalite \u00e9pid\u00e9mique\u00a0: la bradyphrenie","volume":"17","author":"Naville","year":"1922","journal-title":"Encephal"},{"key":"10.1016\/j.neurol.2009.06.003_bib60","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1212\/WNL.46.2.329","article-title":"Testing cognition may contribute to the diagnosis of movement disorders","volume":"46","author":"Pillon","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib61","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.73.6.636","article-title":"Apathy in Parkinson's disease","volume":"73","author":"Pluck","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib62","first-page":"339","article-title":"The premorbid personality of patients with Parkinson's disease: a comparative study with healthy controls and patients with essential tremor","volume":"53","author":"Poewe","year":"1990"},{"key":"10.1016\/j.neurol.2009.06.003_bib63","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neurol.2009.06.003_bib64","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/ncpneuro0680","article-title":"Drug insight: impulse control disorders and dopamine therapies in Parkinson's disease","volume":"3","author":"Potenza","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson's disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib66","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2009.06.003_bib67","first-page":"42","article-title":"Anxiety disorders in Parkinson's disease","volume":"96","author":"Richard","year":"2005","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib68","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/mds.10265","article-title":"Transient mania with hypersexuality after surgery for high frequency stimulation of the subthalamic nucleus in Parkinson's disease","volume":"17","author":"Romito","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib69","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1176\/ajp.145.8.1020","article-title":"Evidence for atypical depression in Parkinson's disease","volume":"145","author":"Schiffer","year":"1988","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1136\/jnnp.69.3.308","article-title":"What contributes to quality of life in patients with Parkinson's disease?","volume":"69","author":"Schrag","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib71","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/mds.1239","article-title":"Poetic talent unmasked by treatment of Parkinson's disease","volume":"16","author":"Schrag","year":"2001","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib72","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/1531-8257(200007)15:4<669::AID-MDS1011>3.0.CO;2-5","article-title":"Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study","volume":"15","author":"Shiba","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib73","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/jnnp.2005.075929","article-title":"The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease","volume":"77","author":"Sockeel","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib74","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neurol.2009.06.003_bib75","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mds.20383","article-title":"Identification of motor and nonmotor wearing-off in Parkinson's disease: comparison of a patient questionnaire versus a clinician assessment","volume":"20","author":"Stacy","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib76","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp.2007.136895","article-title":"The nosological position of apathy in clinical practice","volume":"79","author":"Starkstein","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib77","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson's disease","volume":"4","author":"Starkstein","year":"1992","journal-title":"J Neuropsy Clin Neurosci"},{"key":"10.1016\/j.neurol.2009.06.003_bib78","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-0447.1994.tb01558.x","article-title":"Suicide in patients with Parkinson's disease. An epidemiological study","volume":"90","author":"Stenager","year":"1994","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.neurol.2009.06.003_bib79","unstructured":"Tretiakoff C. (1919). Contribution \u00e0 l\u2019\u00e9tude de l\u2019anatomie pathologique du locus niger de Soemmering avec quelques d\u00e9ductions relatives \u00e0 la pathologie des troubles du tonus musculaire et de la maladie de Parkinson. Th\u00e8se m\u00e9d no\u00a0293, Paris."},{"key":"10.1016\/j.neurol.2009.06.003_bib80","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"\u201cPanic attacks\u201d in Parkinson's disease. A long-term complication of levodopa therapy","volume":"87","author":"Vazquez","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2009.06.003_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/01.wnl.0000238503.20816.13","article-title":"Prevalance of repetitive and reward-seeking behaviors in Parkinson's disease","volume":"67","author":"Voon","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib82","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/brain\/awn214","article-title":"A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease","volume":"131","author":"Voon","year":"2008","journal-title":"Brain"},{"issue":"Suppl. 14","key":"10.1016\/j.neurol.2009.06.003_bib83","first-page":"S305","article-title":"Deep brain stimulation: neuropsychological and neuropsychiatric issues","author":"Voon","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib84","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.30.4.368","article-title":"Depressive symptoms in Parkinson patients referred for thalamotomy","volume":"30","author":"Warburton","year":"1967","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2009.06.003_bib85","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archneur.63.7.969","article-title":"Association of dopamine agonist use with impulse control disorders in Parkinson disease","volume":"63","author":"Weintraub","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib86","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/mds.20501","article-title":"Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation","volume":"20","author":"Witjas","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib87","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.59.3.408","article-title":"Nonmotor fluctuations in Parkinson's disease: frequent and disabling","volume":"59","author":"Witjas","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2009.06.003_bib88","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(08)70114-5","article-title":"Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study","volume":"7","author":"Witt","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2009.06.003_bib89","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/mds.21266","article-title":"Pathological crying induced by deep brain stimulation","volume":"22","author":"Wojtecki","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2009.06.003_bib90","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1001\/archneur.1969.00480160015001","article-title":"Treatment of parkinsonism with levodopa","volume":"21","author":"Yahr","year":"1969","journal-title":"Arch Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709003439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378709003439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T14:54:04Z","timestamp":1545058444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378709003439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0035378709003439"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2009.06.003","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}